The Journal of Neuroscience, January 31, 2007, 27(5):1161-1166; doi:10.1523/JNEUROSCI.4560-06.2007
Previous Article | Next Article 
Brief Communications
Acute Hypoxia Activates the Neuroimmune System, Which Diabetes Exacerbates
Daniel R. Johnson,1
Jason C. O'Connor,2
Matthew E. Hartman,1
Richard I. Tapping,3 and
Gregory G. Freund1,2,4
1Department of Animal Sciences, 2Division of Nutritional Science, 3Department of Medical Microbiology, and 4Department of Pathology, Integrative Immunology and Behavior Program, University of Illinois, Urbana, Illinois 61801
Correspondence should be addressed to Dr. Gregory G. Freund, Department of Pathology, College of Medicine, 506 South Mathews Avenue, University of Illinois at Urbana Champaign, Urbana, IL 61801. Email: freun{at}uiuc.edu
Acute hypoxia is experienced in an array of ailments and conditions, including asthma, chronic obstructive pulmonary disease, heart failure, sleep apnea, acute hypotension, and blast lung injury. Classically, infection activates the neuroimmune system, causing loss of interest in the social environment. We report that the non-infectious stimulus acute hypoxia triggers neuroimmune system activation (NSA), causing loss of interest in the social environment, and that recovery from hypoxia-induced NSA is impaired in a mouse model of type 2 diabetes. Importantly, recovery from the behavioral consequences of hypoxia-induced NSA was nearly ablated in MyD88 (myeloid differentiation factor 88) knock-out mice and in mice intracerebroventricularly administered the caspase-1 inhibitor ac-YVAD-CMK (ac-Tyr-Val-Asp-2,6-dimethylbenzoyloxymethylketone). Diabetic mice had prolonged recovery from NSA that could be halved by administration of subcutaneous interleukin-1 (IL-1) receptor antagonist (RA). These results show that acute hypoxia activates the IL-1ß arm of the neuroimmune system, which diabetes exacerbates and treatment with IL-1RA ameliorates.
Key words: IL-1ß; IL-1 receptor antagonist; innate immunity; hypoxia; neuroimmunity; type 2 diabetes; caspase-1; myeloid differentiation factor 88
Received Oct. 20, 2006;
revised Dec. 19, 2006;
accepted Dec. 24, 2006.
Correspondence should be addressed to Dr. Gregory G. Freund, Department of Pathology, College of Medicine, 506 South Mathews Avenue, University of Illinois at Urbana Champaign, Urbana, IL 61801. Email: freun{at}uiuc.edu
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Sherry, S. S. Kim, and G. G. Freund
Accelerated Recovery from Acute Hypoxia in Obese Mice Is Due to Obesity-Associated Up-Regulation of Interleukin-1 Receptor Antagonist
Endocrinology,
June 1, 2009;
150(6):
2660 - 2667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Johnson, C. L. Sherry, J. M. York, and G. G. Freund
Acute Hypoxia, Diabetes, and Neuroimmune Dysregulation: Converging Mechanisms in the Brain
Neuroscientist,
June 1, 2008;
14(3):
235 - 239.
[Abstract]
[PDF]
|
 |
|
eLetters:
Read all eLetters
- Metabolic mediator in diabetic acidosis
- Heikki Savolainen
- J. Neurosci. Online, 1 Feb 2007
[Full text]